Corvus Pharmaceuticals, Inc. (CRVS) Reports In-Line Q2 EPS

Go back to Corvus Pharmaceuticals, Inc. (CRVS) Reports In-Line Q2 EPS
(NASDAQ: CRVS) Delayed: 12.52 +0.29 (2.37%)
Previous Close $12.23    52 Week High $17.77 
Open $12.55    52 Week Low $9.63 
Day High $12.68    P/E N/A 
Day Low $12.43    EPS $0.00 
Volume 165,033